Meeting Videos

The Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer Research

Session 6 Presentation: Olson (24:17 )

Best-practices for conduct of clinical trial for animal patients
Patricia Olson, Independent Advisor on Animal Health/Welfare

  • Session 2 Introduction: Knapp Deborah Knapp
    Purdue University

    Session 2: Canine tumor biology and genomics informing cancer drug...

  • Session 2 Presentation: Parker Heidi Parker
    National Institutes of Health

    The current state of canine tumor genetics and scientific limitations Heidi Parker,...

  • Session 2 Presentation: Breen Matthew Breen
    North Carolina State University

    Use and availability of canine cancer tissue banks in translational research Matthew...

  • Session 5 Discussion Panelists
    Institute of Medicine

    Discussion and panelists field questions from the audience.

  • Session 3 Presentation: Thamm Doug Thamm
    Colorado State University

    PD and potential predictive biomarkers Doug Thamm, Colorado State University

  • Session 3 Discussion Speakers
    Institute of Medicine

    Session 3 Discussion and panelists field questions from the audience.

  • Session 6 Introduction: Lairmore Michael Lairmore
    University of California-Davis

    Addressing the needs of pet animals and their owners Moderator: Michael Lairmore,...

  • Session 6 Presentation: Vail David Vail
    University of Wisconsin

    Trial design and appropriate oversight David Vail, University of Wisconsin

  • Session 6 Presentation: Page Rod Page
    Colorado State University

    Best-practices for conduct of clinical trial for animal patients Rod Page, Colorado...

  • Session 6 Presentation: Olson Patricia Olson
    Independent Advisor on Animal Health/Welfare

    Best-practices for conduct of clinical trial for animal patients Patricia Olson,...

  • Session 6 Discussion Speakers
    Institute of Medicine

    Discussion and panelists field questions from the audience.

  • Workshop Wrap Up Speakers
    Institute of Medicine

    Deborah Knapp, Purde University Len Lichtenfeld, American Cancer Society

  • Session 1 Presentation: Khanna Chand Khanna
    National Cancer Institute

    Advantages and experiences with trials that include animal patients Chand Khanna,...

  • Session 1 Discussion Speakers
    Institute of Medicine

    Session 1 Discussion and panelists field questions from audience.

Introduction to Welcome Speaker
Sharyl Nass
Institute of Medicine

Introduction By Sharyl Nass, Institute of Medicine

Session 1 Discussion
Speakers
Institute of Medicine

Session 1 Discussion and panelists field questions from audience.

Session 1 Presentation: Helman
Lee Helman
National Cancer Institute

Overview of current challenges and opportunities in oncology drug development Lee...

Session 1 Presentation: Khanna
Chand Khanna
National Cancer Institute

Advantages and experiences with trials that include animal patients Chand Khanna,...

Session 1 Presentation: Teicher
Beverly Teicher
National Cancer Institute

Strengths and limitations of traditional pre-clinical models Beverly Teicher, National...

Session 2 Discussion
Speakers
Institute of Medicine

Discussion and Q&A with audience.

Session 2 Introduction: Knapp
Deborah Knapp
Purdue University

Session 2: Canine tumor biology and genomics informing cancer drug...

Session 2 Presentation: Alfoldi
Jessica Alföldi
Broad Institute of MIT and Harvard

Genomic resources for canine cancer research Jessica Alföldi, Broad Institute of MIT and ...

Session 2 Presentation: Breen
Matthew Breen
North Carolina State University

Use and availability of canine cancer tissue banks in translational research Matthew...

Session 2 Presentation: Parker
Heidi Parker
National Institutes of Health

The current state of canine tumor genetics and scientific limitations Heidi Parker,...

Session 2 Presentation: Trent
Jeff Trent
TGEN

Biology and informatics needs Jeff Trent, TGEN

Session 3 Discussion
Speakers
Institute of Medicine

Session 3 Discussion and panelists field questions from the audience.

Session 3 Introduction: Barrett
Carl Barrett
AstraZeneca

Session 3: Effectively integrating biomarkers into study designs Moderator: Carl...

Session 3 Presentation: Fan
Timothy Fan
University of Illinois at Urbana-Champaign

Opportunities for preclinical evaluation of novel therapies Timothy Fan, University of...

Session 3 Presentation: Gustafson
Dan Gustafson
Colorado State University

PK assessment Dan Gustafson, Colorado State University

Session 3 Presentation: Thamm
Doug Thamm
Colorado State University

PD and potential predictive biomarkers Doug Thamm, Colorado State University

Session 4 Discussion
Speakers
Institute of Medicine

Discussion and panelists field questions from the audience.

Session 4 Introduction and Presentation: Choyke
Peter Choyke
National Cancer Institute

Session 4: Effectively integrating imaging technologies into study designs Moderator:...

Session 4 Presentation: Dewhirst
Mark Dewhirst
Duke University

MRI spectroscopy Mark Dewhirst, Duke University

Session 5 Discussion
Panelists
Institute of Medicine

Discussion and panelists field questions from the audience.

Session 5 Introduction: DeGennaro
Lou DeGennaro
Leukemia and Lymphoma Society

Session 5: Mechanisms for Comparative Oncology Trials Moderator: Lou DeGennaro, Leukemia ...

Session 5 Presentation: LeBlanc
Amy LeBlanc
National Cancer Institute

Multi-institution studies Amy LeBlanc, National Cancer Institute

Session 5 Presentation: London
Cheryl London
Ohio State University

Single-institution studies Cheryl London, Ohio State University

Session 6 Discussion
Speakers
Institute of Medicine

Discussion and panelists field questions from the audience.

Session 6 Introduction: Lairmore
Michael Lairmore
University of California-Davis

Addressing the needs of pet animals and their owners Moderator: Michael Lairmore,...

Session 6 Presentation: Olson
Patricia Olson
Independent Advisor on Animal Health/Welfare

Best-practices for conduct of clinical trial for animal patients Patricia Olson,...

Session 6 Presentation: Page
Rod Page
Colorado State University

Best-practices for conduct of clinical trial for animal patients Rod Page, Colorado...

Session 6 Presentation: Vail
David Vail
University of Wisconsin

Trial design and appropriate oversight David Vail, University of Wisconsin

Session 7 Discussion
Speakers
Institute of Medicine

Discussion and panelists field questions from the audience.

Session 7 Introduction: Nisen
Perry Nisen
Sanford-Burnham Research Institute

The status of comparative oncology in drug development Perry Nisen, Sanford-Burnham...

Session 7 Presentation: Keane
Anne Keane
Achaogen

Panelist - Anne Keane, Achaogen

Session 7 Presentation: Levin
Wendy Levin
MEI Pharma

Panelist - Wendy Levin, MEI Pharma

Session 7 Presentation:Leighton
John Leighton
Food and Drug Adminstration

Panelist - John Leighton, Food and Drug Adminstration

Session 7 Presentation:Tumas
Daniel Tumas
Gilead Sciences, Inc.

Panelist - Daniel Tumas, Gilead Sciences, Inc.

Welcome, Workshop Overview and Introduction to Session 1
Michael Kastan
Duke University

Michael Kastan (Duke) Planning Committee Chair

Workshop Wrap Up
Speakers
Institute of Medicine

Deborah Knapp, Purde University Len Lichtenfeld, American Cancer Society

Activity Staff

  • Sharyl Nass, Activity Director
  • View Full Activity Staff Roster

    • Erin Balogh

    • Emily Zevon

    • Annalee Gonzales

    • Ruth Cooper

Activity Contact Information

For More Information Contact

Ruth Cooper
Phone:
202-334-3125
Fax:
202-334-2647
E-mail:
Rcooper@nas.edu

Mailing Address


Keck Center
500 Fifth St. NW
Washington, DC 20001

Video Search